Item 5.07. Submission of Matters to a Vote of Security Holders.

On November 15, 2021, Sorrento Therapeutics, Inc. (the "Company") held its 2021 Annual Meeting of Stockholders (the "Meeting"). At the Meeting, a total of 197,375,474 shares, or 65.2% of the Company's common stock issued and outstanding as of the record date, were represented virtually or by proxy.

At the Meeting, the Company's stockholders considered five proposals, each of which is described in more detail in the Company's definitive proxy statement for the Meeting filed with the Securities and Exchange Commission on October 5, 2021 (the "Proxy Statement").

Set forth below is a brief description of each matter voted upon at the Meeting and the voting results with respect to each matter.

Proposal No. 1: To elect the following nominees as directors to serve until the Company's 2022 Annual Meeting of Stockholders.



        Nominee             For      Withhold  Broker Non-Votes
Henry Ji, Ph.D.         107,838,307 7,402,419     82,134,748
Dorman Followwill       98,175,942  17,064,784    82,134,748
Kim D. Janda, Ph.D.     97,702,123  17,538,603    82,134,748
David Lemus             109,222,911 6,017,815     82,134,748
Jaisim Shah             103,701,987 11,538,739    82,134,748

Yue Alexander Wu, Ph.D. 100,730,822 14,509,904 82,134,748 Elizabeth A. Czerepak 109,434,794 5,805,932 82,134,748

Proposal No. 2: To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2021.



    For      Against  Abstentions
190,806,630 3,716,327  2,852,517

Proposal No. 3: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.

For Against Abstentions Broker Non-Votes 72,052,085 41,686,183 1,502,458 82,134,748

Proposal No. 4: To approve, on an advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers in the Proxy Statement.

1 Year 2 Years 3 Years Abstentions Broker Non-Votes 108,110,293 1,667,870 2,895,139 2,567,424 82,134,748

In light of the advisory vote of the Company's stockholders to hold future advisory votes on the compensation of the Company's named executive officers every year, the Company has determined that it will hold future advisory votes on the compensation of the Company's named executive officers on an annual basis until the next stockholder advisory vote on the frequency of advisory votes on the compensation of the Company's named executive officers.

Proposal No. 5: To approve the compensation of Dr. Henry Ji as Executive Chairperson of Scilex Holding Company.

For Against Abstentions Broker Non-Votes 41,968,730 71,798,133 1,473,863 82,134,748




--------------------------------------------------------------------------------

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.



104   Cover Page Interactive Data File, formatted in Inline Extensible Business
      Reporting Language (iXBRL).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses